Cardica Inc: (NASD: CRDC)
$1.27
-0.01 (-0.78%)
Volume 12,103
May 22 04:00 PM ET
Zacks Rank: 3-Hold 
| #3 |
Overview Quote
Stock Activity
| Day Low - High | 1.26 - 1.30 |
| 52wk Low - High | 0.67 - 1.99 |
| Previous Close | 1.28 |
| Avg. Volume | 47,463 |
| Industry | MED PRODUCTS |
| Market Cap | 65.54 M |
| Div - Yield | 0.00 - 0.00 |
| Beta | 1.08 |
| PE (Forward) | 0.00 |
| Current Year Est. | -0.41 |
| Quarterly Earnings ESP |
NA |
Premium research
Zacks Rank
|
3 |
Zacks Recommendation
|
Neutral |
Zacks Industry Rank
|
177 out of 265 |
Equity Research Report
|
PREMIUM |
( = Change in last 30 days)
Get all our stock ratings and recommendations with a Free Trial to Zacks Premium Start Free Trial
Key Earnings Data
| PE (Forward) | NA |
| PEG Ratio | NA |
| Current Year Est. | -0.41 |
| Current Quarter Estimate | -0.08 |
| Most Accurate Estimate | NA |
| Earnings ESP |
NA |
| Next Earnings Report Date | 08-08-2013 |
| EPS Last Year | -0.42 |
| Expected Earnings Growth | NA |
Company Description
Cardica, Inc. designs and manufactures proprietary automated anastomotic systems used by surgeons to perform coronary artery bypass graft surgery. In these surgery procedures, veins or arteries are used to construct alternative conduits to restore blood flow beyond narrowed or occluded portions of coronary arteries, bypassing the narrowed or occluded portion of the artery that is impairing blood flow to the heart muscle. Our first two products, the C-Port Distal Anastomosis System, and the PAS-Port Proximal Anastomosis System, provide cardiovascular surgeons with easy-to-use automated systems to perform consistent, rapid and reliable connections, or anastomoses, of the vessels, which surgeons generally view as the most critical aspect of the bypass procedure.
NYSE data is at least 20 minutes delayed.
NASDAQ data is at least 15 minutes delayed.
Turn Earnings Surprises into quick profits.
Earnings Estimates
| Current Qtr (06/2013) |
Next Qtr (09/2013) |
Current Year (06/2013) |
Next Year (06/2014) |
|
|---|---|---|---|---|
| Average Estimate | -0.08 | NA | -0.41 | -0.29 |
| Number of Estimates | 1 | 0 | 1 | 1 |
| Low Estimate | -0.08 | NA | -0.41 | -0.29 |
| High Estimate | -0.08 | NA | -0.41 | NA |
| Year Ago EPS | -0.10 | -0.11 | -0.44 | -0.41 |
| EPS Growth | 20.00% | NA | 6.82% | 29.27% |
Industry Analysis
| Name | Symbol | Previous Close | Zacks Rank | Zacks Recommendation |
|---|---|---|---|---|
| CARDICA INC | CRDC | 1.28 | |
|
| CONCEPTUS INC | CPTS | 30.98 | |
|
| ATRICURE INC | ATRC | 8.99 | |
|
| INVIVO THERAPT | NVIV | 2.90 | |
|
| TRANS1 INC | TSON | 1.59 | |
|
| ABAXIS INC | ABAX | 44.22 | |
|
| ADVAXIS INC | ADXS | 0.05 | |
|
| BAXTER INTL | BAX | 73.04 | |
|
| BIO-RAD LABS -A | BIO | 116.12 | |
|
| BIOLIFE SOL INC | BLFS | 0.38 | |
|
Sector:Medical>> Industry:MED PRODUCTS
COMPARE TICKER vs. Its Peers
Financials
| EPS TTM | -0.42 |
| Sales | 4 |
| Net Income | -16 |
| Price/Earnings | NA |
| Price/Book | 4.44 |
| Price/Cash Flow | NA |
| Price/Sales | 18.34 |
News
Cardica Finalizes Enrollment In European Clinical Trial for Surgical Cutting and Stapling Device - Close-Up Media
May 21, 2013
Interventional Cardiology Devices - Emerging Markets (Brazil, Russia, India, China, South Africa And South Korea), 2009-2015 - M2
May 20, 2013
Cardica Completes Enrollment In European Clinical Trial For Surgical Cutting And Stapling Device - Pr Newswire
May 15, 2013
Cardica Q3 net loss increases - Datamonitor
May 10, 2013
Cardica Inc.Corporate Event Announcement Notice - Wall Street Horizon
May 1, 2013
Cardiac Rhythm Management (CRM) Devices - Emerging Markets (Brazil, Russia, India, China, South Africa And South Korea), 2009-2015 - M2
Apr 30, 2013
Cardica Announces Fiscal 2013 Third Quarter Financial Results - Pr Newswire
Apr 30, 2013
Cardica Inc.Corporate Event Announcement Notice - Wall Street Horizon
Apr 30, 2013
Broker Recommendations
| Current ABR | 1.00 |
| ABR (Last Week) | 1.00 |
| # of recs in ABR | 1 |
| Average Target Price | 4.00 |
| Industry Rank by ABR | 177 out of 265 |
| Rank in Industry | 5 out of 73 |
